BIO’s new board chair on drug pricing, diversity, and going off-script - STAT

BIO’s new board chair on drug pricing, diversity, and going off-script - STAT

STAT Plus: BIO’s new board chair on drug pricing, diversity, and going off-script

By KATE SHERIDAN

OVID

Jeremy Levin, BIO's new board chair, is a doctor, a gun owner, an immigrant, and the former CEO of the largest generic drug manufacturer in the world.

READ MORE